IBDEI1JE ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24876,1,4,0)
 ;;=4^K08.89
 ;;^UTILITY(U,$J,358.3,24876,2)
 ;;=^5008467
 ;;^UTILITY(U,$J,358.3,24877,0)
 ;;=B97.89^^85^1095^7
 ;;^UTILITY(U,$J,358.3,24877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24877,1,3,0)
 ;;=3^Viral Agents as the Cause of Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,24877,1,4,0)
 ;;=4^B97.89
 ;;^UTILITY(U,$J,358.3,24877,2)
 ;;=^5000879
 ;;^UTILITY(U,$J,358.3,24878,0)
 ;;=H54.7^^85^1095^8
 ;;^UTILITY(U,$J,358.3,24878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24878,1,3,0)
 ;;=3^Visual Loss,Unspec
 ;;^UTILITY(U,$J,358.3,24878,1,4,0)
 ;;=4^H54.7
 ;;^UTILITY(U,$J,358.3,24878,2)
 ;;=^5006368
 ;;^UTILITY(U,$J,358.3,24879,0)
 ;;=I83.91^^85^1095^5
 ;;^UTILITY(U,$J,358.3,24879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24879,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Right Lower Extremity
 ;;^UTILITY(U,$J,358.3,24879,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,24879,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,24880,0)
 ;;=I83.92^^85^1095^4
 ;;^UTILITY(U,$J,358.3,24880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24880,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Left Lower Extremity
 ;;^UTILITY(U,$J,358.3,24880,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,24880,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,24881,0)
 ;;=I83.93^^85^1095^3
 ;;^UTILITY(U,$J,358.3,24881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24881,1,3,0)
 ;;=3^Varicose Veins,Asymptomatic,Bilateral Lower Extremities
 ;;^UTILITY(U,$J,358.3,24881,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,24881,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,24882,0)
 ;;=R53.1^^85^1095^9
 ;;^UTILITY(U,$J,358.3,24882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24882,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,24882,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,24882,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,24883,0)
 ;;=R63.4^^85^1095^10
 ;;^UTILITY(U,$J,358.3,24883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24883,1,3,0)
 ;;=3^Weight Loss,Abnormal
 ;;^UTILITY(U,$J,358.3,24883,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,24883,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,24884,0)
 ;;=B02.9^^85^1095^11
 ;;^UTILITY(U,$J,358.3,24884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24884,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,24884,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,24884,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,24885,0)
 ;;=I49.3^^85^1095^6
 ;;^UTILITY(U,$J,358.3,24885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24885,1,3,0)
 ;;=3^Vetricular Premature Depolarization
 ;;^UTILITY(U,$J,358.3,24885,1,4,0)
 ;;=4^I49.3
 ;;^UTILITY(U,$J,358.3,24885,2)
 ;;=^5007233
 ;;^UTILITY(U,$J,358.3,24886,0)
 ;;=I83.019^^85^1095^2
 ;;^UTILITY(U,$J,358.3,24886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24886,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,24886,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,24886,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,24887,0)
 ;;=I83.029^^85^1095^1
 ;;^UTILITY(U,$J,358.3,24887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24887,1,3,0)
 ;;=3^Varicose Veins Left Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,24887,1,4,0)
 ;;=4^I83.029
 ;;^UTILITY(U,$J,358.3,24887,2)
 ;;=^5007986
 ;;^UTILITY(U,$J,358.3,24888,0)
 ;;=Z01.818^^85^1096^3
 ;;^UTILITY(U,$J,358.3,24888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24888,1,3,0)
 ;;=3^Preporcedural Exam NEC
 ;;^UTILITY(U,$J,358.3,24888,1,4,0)
 ;;=4^Z01.818
